Transcatheter Embolization and Occlusion Devices | Market Insights | Europe (Supplemental) | 2022
While the COVID-19 pandemic had a negative, albeit relatively limited, impact on the European TEO device market in the short term, the market will grow modestly over the forecast period, driven by an expanding patient population, improved reimbursement leading to the adoption of innovative and premium-priced products backed by favorable clinical data, rising penetration, and increased physician training on endovascular embolization in new indications.
This Medtech 360 Report provides high-level market metrics for TEO devices in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 11-year period.
